|Print Page Close Window|
Stereotaxis is the global leader in innovative robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. Its mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide unsurpassed patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. Over 100 issued patents support the Stereotaxis platform. Stereotaxis' core Epoch™ Solution includes the Niobe® ES remote magnetic navigation system, the Odyssey® portfolio of lab optimization, networking and patient information management systems, and the Vdrive™ robotic navigation system and consumables, which have received regulatory clearance in the United States, European Union, Japan, Canada, China, and elsewhere.
European Heart Rhythm Association Highlights Occupational Risk of Radiation Exposure in Electrophysiology Procedures
Stereotaxis technology included in recommendations to reduce fluoroscopy exposure and described as a
Revenue of $7.6 million for the fourth quarter and $31.2 million for the full year 2017 Fourth qu
First Procedures Performed at Toronto’s Sunnybrook Health Sciences Centre ST. LOUIS, Dec. 05, 2017
Powered By EDGAR Online